You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 93 No. 5, MAY 1954 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

SOME STUDIES OF NATURE AND CLINICAL SIGNIFICANCE OF PORPHOBILINOGEN

C. J. WATSON, M.D.

AMA Arch Intern Med. 1954;93(5):643-657.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT HAS been known for many years that the urine Ehrlich reaction is strongly positive in cases of acute porphyria. This was generally interpreted as due to excessive urobilinogen until 1931, when Paula Sachs1 clearly distinguished this substance from the Ehrlich-reacting chromogen in porphyria urines. She based the distinction on differences in solubility and the failure of the porphyria chromogen upon oxidation to exhibit green fluorescence with zinc acetate. Rather, it was oxidized to a brown pigment differing from urobilin and believed to represent what the older literature had rather vaguely designated as "urofuscin." Waldenström2 spoke of this as the "red pigment," and still later Waldenström and Vahlquist3 studied the chromogen in more detail, confirming the observation that, unlike urobilinogen, it is not extracted from urine by most organic solvents. They noted that the Ehrlich aldehyde compound, in addition to the strong absorption band at 550 to . . . [Full Text PDF of this Article]


Author Affiliations

With the Technical Assistance of Violet Hawkinson, B.S., and Irene Bossenmaier, B.S. MINNEAPOLIS

From the Department of Medicine, University of Minnesota Medical School and Hospital.


Footnotes

Presented in part before the Association of American Physicians, Atlantic City, N. J., May 5, 1953.

Supported in part by the John and Mary Briggs Fund for research on Porphyria and under contracts with the Atomic Energy Commission and the Surgeon General's Office, United States Army, under sponsorship of the Commission on Liver Disease, Armed Forces Epidemiological Board.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1954 American Medical Association. All Rights Reserved.